Pelley R - Search Results

1

Amifostine: potential for clinically useful cytoprotection.

Budd GT, Lorenzi V, Ganapathi R, Adelstein D, Pelley R, Olencki T, McLain D, Bukowski RM. Budd GT, et al. Among authors: pelley r. Support Care Cancer. 1994 Nov;2(6):380-4. doi: 10.1007/BF00344052. Support Care Cancer. 1994. PMID: 7858931 Review.

2

Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies.

Mekhail T, Hutson TE, Elson P, Budd GT, Srkalovic G, Olencki T, Peereboom D, Pelley R, Bukowski RM. Mekhail T, et al. Among authors: pelley r. Cancer. 2003 Jan 1;97(1):170-8. doi: 10.1002/cncr.10991. Cancer. 2003. PMID: 12491518 Free article. Clinical Trial.

3

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors.

Budd GT, Ganapathi R, Adelstein DJ, Pelley R, Olencki T, Petrus J, McLain D, Zhang J, Capizzi R, Bukowski RM. Budd GT, et al. Among authors: pelley r. Cancer. 1997 Sep 15;80(6):1134-40. Cancer. 1997. PMID: 9305715 Clinical Trial.

4

A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer.

Pelley R, Ganapathi R, Wood L, Rybicki L, McLain D, Budd GT, Peereboom D, Olencki T, Bukowski RM. Pelley R, et al. Cancer Chemother Pharmacol. 2000;46(3):251-4. doi: 10.1007/s002800000139. Cancer Chemother Pharmacol. 2000. PMID: 11021744 Clinical Trial.

5

Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.

Pelley RJ, Bukowski RM. Pelley RJ, et al. Curr Opin Oncol. 1997 Jan;9(1):68-74. doi: 10.1097/00001622-199701000-00011. Curr Opin Oncol. 1997. PMID: 9090496 Review.

6

Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors.

Pelley RJ, Bukowski RM. Pelley RJ, et al. Curr Opin Oncol. 1999 Jan;11(1):32-7. doi: 10.1097/00001622-199901000-00008. Curr Opin Oncol. 1999. PMID: 9914875 Review.

7

Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas.

Chidiac T, Budd GT, Pelley R, Sandstrom K, McLain D, Elson P, Crownover R, Marks K, Muschler G, Joyce M, Zehr R, Bukowski R. Chidiac T, et al. Among authors: pelley r. Invest New Drugs. 2000 Aug;18(3):253-9. doi: 10.1023/a:1006429907449. Invest New Drugs. 2000. PMID: 10958594 Clinical Trial.

8

Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumors.

Kalmadi S, Davis M, Dowlati A, O'Keefe S, Cline-Burkhardt M, Pelley RJ, Borden E, Dreicer R, Bukowski R, Mekhail T. Kalmadi S, et al. Among authors: pelley rj. Invest New Drugs. 2007 Jun;25(3):211-6. doi: 10.1007/s10637-006-9025-4. Epub 2006 Nov 11. Invest New Drugs. 2007. PMID: 17103043 Clinical Trial.

9

A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer.

Laheru D, Croghan G, Bukowski R, Rudek M, Messersmith W, Erlichman C, Pelley R, Jimeno A, Donehower R, Boni J, Abbas R, Martins P, Zacharchuk C, Hidalgo M. Laheru D, et al. Among authors: pelley r. Clin Cancer Res. 2008 Sep 1;14(17):5602-9. doi: 10.1158/1078-0432.CCR-08-0433. Clin Cancer Res. 2008. PMID: 18765554 Free PMC article. Clinical Trial.

10

Prospective Clinical Study of Precision Oncology in Solid Tumors.

Sohal DP, Rini BI, Khorana AA, Dreicer R, Abraham J, Procop GW, Saunthararajah Y, Pennell NA, Stevenson JP, Pelley R, Estfan B, Shepard D, Funchain P, Elson P, Adelstein DJ, Bolwell BJ. Sohal DP, et al. Among authors: pelley r. J Natl Cancer Inst. 2015 Nov 9;108(3):djv332. doi: 10.1093/jnci/djv332. J Natl Cancer Inst. 2015. PMID: 26553780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page